Affle (India) Limited vs Lupin Limited
Put two companies head-to-head — source-verified financials and AI-analysed SWOT, together in one view.
Affle (India) Limited (Advertising technology) and Lupin Limited (Pharmaceuticals) go head-to-head here — with source-verified financials and a full SWOT breakdown side by side on Nexvora Intelligence. On the figures reported, Affle (India) Limited leads on Revenue (approx.).
Affle (India) Limited leads on Revenue (approx.).
Head-to-head highlights
| Metric | Affle (India) Limited | Lupin Limited | Basis |
|---|---|---|---|
| Revenue (approx.) | Approximately ₹1,800-1,900 crore | Approximately ₹190-210 billion, roughly US$2.3-2.6 billion; unverified range | AI estimate |
An arrow marks the larger reported figure — a factual comparison, not a quality judgement. Verified figures come from official filings; AI estimates are approximate and unverified.
Affle (India) Limited
Advertising technology · India
Affle (India) Limited is an Indian advertising technology company focused on mobile marketing, user acquisition, and consumer intelligence. Its platforms help advertisers acquire, engage, and monetize users across mobile apps and digital channels, with a strong focus on India and other emerging markets.
Verified financials
No source-verified financials available.
Strengths
- Strong mobile-first adtech specialization
- Performance-based advertising model aligned with advertiser ROI
- Presence across India, Southeast Asia, and other growth markets
- Portfolio expanded through acquisitions such as Jampp, mediasmart, and RevX
Weaknesses
- Smaller scale than global platform giants
- Dependence on mobile advertising budgets
- Business complexity from multiple acquired platforms
- Exposure to margin pressure in competitive performance marketing
Opportunities
- Growth in mobile app ecosystems across emerging markets
- Rising advertiser demand for measurable performance marketing
- Expansion of AI-driven campaign optimization and consumer intelligence
- Cross-selling across acquired adtech platforms
Threats
- Privacy regulation and mobile identifier restrictions
- Competition from large walled-garden platforms
- Ad fraud and brand-safety concerns in digital advertising
- Macroeconomic slowdowns affecting advertising spend
Lupin Limited
Pharmaceuticals · India
Lupin Limited is an Indian multinational pharmaceutical company focused on generic and branded formulations, active pharmaceutical ingredients, biosimilars, and specialty products. It has a significant presence in India, the United States, and other international markets, with strengths in therapeutic areas such as respiratory, cardiovascular, diabetes, anti-infectives, and central nervous system medicines.
Verified financials
No source-verified financials available.
Strengths
- Established global generics platform
- Strong presence in India and the U.S.
- Capabilities in complex generics and respiratory products
- Broad manufacturing and R&D base
Weaknesses
- Exposure to U.S. generic pricing pressure
- Regulatory scrutiny of manufacturing sites
- Dependence on successful product approvals
- Margin volatility from product mix and compliance costs
Opportunities
- Growth in complex generics and inhalation therapies
- Expansion in biosimilars and specialty pharmaceuticals
- Increasing demand for affordable medicines globally
- Geographic expansion in emerging and European markets
Threats
- Intense competition in generic pharmaceuticals
- Delays or setbacks in regulatory approvals
- Currency and input-cost volatility
- Patent litigation and compliance risks
Frequently asked
Answered from source-verified figures on this page.
Affle (India) Limited vs Lupin Limited: which company leads overall?
Affle (India) Limited leads on Revenue (approx.).
Related market reports
Deep-dive intelligence on the markets these companies compete in.
Global Streaming & Connected TV Advertising Market — Intelligence Report
India Protein Industry Outlook — Intelligence Report
India Pharmaceutical Sector — Intelligence Report
Global Radiopharmaceuticals and Theranostics Market — Intelligence Report
AI Analyst
Insights and answers generated live from Affle (India) Limited vs Lupin Limited's verified data. Modeled estimates — not investment advice.
Not enough data yet to generate insights.